| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 339638 | 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt | 0.0115521552688255 | 0.20374468 |
| NSC 352741 | Null | 0.0115521552688255 | 0.31962049 |
| NSC 54849 | Null | 0.0115521552688255 | 0.16737352 |
| NSC 618262 | Null | 0.0115521552688255 | 0.35266567 |
| NSC 623527 | Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt | 0.0115521552688255 | 0.25194256 |
| NSC 626673 | Null | 0.0115521552688255 | 0.21427636 |
| NSC 630307 | Null | 0.0115521552688255 | 0.40036891 |
| NSC 639503 | Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride | 0.0115521552688255 | 0.46028663 |
| NSC 639512 | Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride | 0.0115521552688255 | 0.3051308 |
| NSC 641297 | ANTINEOPLASTIC-641297 | 0.0115521552688255 | 0.2184319 |